#National Institutes of Health

Aside from taking antiretrovirals, quitting smoking is the number one way people with HIV can lower their risk of illness and death.

Researchers will genetically engineer participants’ CD4 cells, disabling the attachment of the virus.

At stake in amfAR’s civil war is the nonprofit’s quest to find a cure for HIV.

The CDC would keep fewer than 40 percent on employers on the job—and this is during a deadly flu outbreak.

This NIH study closely monitored 10 people with HIV who stopped antiretroviral treatment for weeks to months in a larger cure study.

A $3.4 million grant funds research about the HIV prevention pill in Milwaukee and Cleveland.

A one-month version of the ring is currently up for regulatory approval.

Courting controversy, the NIH considers a shift away from the development of new vaginal or rectal-based HIV prevention products.

A statement from the National Institutes of Health on World AIDS Day 2017.

A trial of long-acting cabotegravir injected every eight weeks is already under way among men who have sex with men and trans women.

The study of a vaccine that is designed to prevent multiple strains of the virus will include 2,600 women in sub-Saharan Africa.

A federal grant will help develop an HIV prevention app called Transwoman Connected.

Three antibodies combined into one protected monkeys against a simian version of HIV, opening the door for human trials.

Researchers have succeeded in immunizing calves and prompting them to produce so-called broadly neutralizing antibodies against HIV.

HIV scientists and advocates are waging a powerful war against the global epidemic.

See a “POZ on Location” video with highlights from the United States Conference on AIDS and scroll through 15 tweets from HIV advocates.